US FDA has granted clearance of DaylightRx for generalized anxiety disorder
-
learn more here.
Solutions
Research
Company
Get Started
US
Who we serve
Health Systems & Practices
Health Plans
Employers
Safe and effective digital CBT for insomnia and anxiety
offerings
For insomnia
For anxiety
Increase access to first-line mental health care for members
Explore all health plan solutions
offerings
For insomnia
For anxiety
Provide effective mental health care for your organization
Explore all employer solutions
offerings
For better sleep
For improved mood
For reduced worry and anxiety
For comprehensive mental health care
BIG HEALTH
About Us
Our mission & team
News & Resources
Learn with us
Careers
Join our mission
FAQ
We’ve got answers
Our Solutions
Sleepio
Sleepio Rx
Daylight
Daylight Rx
Spark Direct
For Organizations
Research
Resources
Blog
News
Webinars
Reports
Tools
User Stories
Contact Us
Request Demo
US
UK
Latest news
March 24, 2025
/
News
FDA-Cleared Digital Treatments are Shaping the Future of Mental Healthcare
New JAMA Study Showcases Clinical Benefits of SleepioRx in Patients with Comorbid Insomnia and Depression Symptoms, Marking 100+ Peer-Reviewed Papers for Big Health
March 10, 2025
/
News
US FDA Grants Clearance for DaylightRx
September 4, 2024
/
News
US FDA Grants Clearance for SleepioRx
August 8, 2024
/
News
Study Finds Spark Direct Effective in Improving Mood Among Adults With Depression
May 23, 2024
/
News
All News
The mental health system of the future, delivered today
While the COVID public health emergency may have ended, the global mental health crisis certainly has not.
January 2, 2024
/
News
The mental health system of the future, delivered today
While the COVID public health emergency may have ended, the global mental health crisis certainly has not. Our global health systems’ capacity to meet mental health needs is more strained than ever. Data just released by the American Psychological Association (APA) show that patients are presenting with more severe mental health symptoms, wait times are growing significantly, and access to care is shrinking.
January 2, 2024
/
News
New Research Demonstrates Clinical Effectiveness of Digital Treatment at Improving Insomnia and Comorbid Mental and Physical Health Issues
Findings advance the clinical evidence foundation demonstrating that Sleepio, a digital cognitive behavioral therapeutic for insomnia, is a safe and effective, non-drug alternative to treating global, co-occurring conditions
October 9, 2023
/
News
New Research Demonstrates Clinical Effectiveness of Digital Treatment at Improving Insomnia and Comorbid Mental and Physical Health Issues
Findings advance the clinical evidence foundation demonstrating that Sleepio, a digital cognitive behavioral therapeutic for insomnia, is a safe and effective, non-drug alternative to treating global, co-occurring conditions
October 9, 2023
/
News
Supporting clinicians with effective digital treatments
Big Health partners with the American Psychological Association to increase awareness of the value and impact of digital treatments in clinical care delivery.
August 10, 2023
/
News
Accelerating Our Mission, Expanding Our Platform
Big Health Adds Clinically Proven Digital Therapeutics to Treat Adolescent Depression and Anxiety
July 14, 2023
/
News
Previous
Load More
Let's talk
For all media-related queries, please get in touch with us.
press@bighealth.com
Who we are
Learn about our mission, leadership, advisors, and investors.
About us